Related Experiment Video
Updated: Apr 20, 2026

Retinal Pathophysiological Evaluation in a Rat Model
Published on: May 6, 2022
Ras-related C3 botulinum toxin substrate 1 activation is involved in the pathogenesis of diabetic retinopathy
Yang-Jun Li1, Jie Zhang1, Jing Han1
1Department of Ophthalmology, Tangdu Hospital, The Fourth Military Medical University of the PLA, Xian, Shaanxi 710038, P.R. China.
Abstract:
This study used a streptozotocin (STZ)-induced rat model of diabetes to investigate whether Ras-related C3 botulinum toxin substrate 1 (Rac1) was involved in the pathogenesis of diabetic retinopathy. The effects of Rac1 inhibition on vascular endothelial (VE)-cadherin and β-catenin expression in high glucose-induced rat retinal endothelial cells (RRECs) were additionally examined. Rac1 activation in the retinas from STZ-induced diabetic rats and in high glucose-induced RRECs was measured by reverse transcription-quantitative polymerase chain reaction analysis, immunohistochemistry and western blot analysis. The expression levels of VE-cadherin and β-catenin were also examined with or without Rac1 inhibition through small interfering (si)RNA transfection. STZ-induced diabetes was associated with an increase in the vascular permeability of the retina. Furthermore, Rac1 activation was increased in the retina of STZ-induced diabetic rats and in high glucose-induced RRECs compared with that in the controls. Immunohistochemistry showed that immunostaining of Rac1 was localized in the outer plexiform, inner nuclear, inner plexiform and ganglion cell layers and in the retinal microvasculature of rats. The expression of β-catenin was increased in the retinas of the diabetic rats at four, eight and 12 weeks after the induction of diabetes compared with that in the controls. Additionally, Rac1 activation was required for the high glucose-induced VE-cadherin expression decrease and for β-catenin expression in high glucose-induced RRECs. Rac1 inhibition by Rac1-siRNA transfection effectively prevented hyperpermeability, β-catenin expression and the VE-cadherin expression decrease in high glucose-induced RRECs. In conclusion, diabetes affects the expression of Rac1 in the retina. Rac1 may be involved in the diabetes-induced damage and/or alterations to the blood-retinal barrier through changes in VE-cadherin and β-catenin expression.
Insights
Diabetic retinopathy involves increased Ras-related C3 botulinum toxin substrate 1 (Rac1) activation. Inhibiting Rac1 in retinal cells reduced vascular permeability and normalized key protein expressions, suggesting Rac1’s role in diabetic retinal damage.
Area of Science:
- Biomedical Science
- Ophthalmology
- Molecular Biology
Background:
- Diabetic retinopathy is a leading cause of vision loss.
- The role of specific signaling pathways, like Ras-related C3 botulinum toxin substrate 1 (Rac1), in diabetic retinopathy pathogenesis is not fully understood.
- Alterations in blood-retinal barrier integrity are a hallmark of diabetic retinopathy.
Purpose of the Study:
- To investigate the involvement of Rac1 in the pathogenesis of diabetic retinopathy.
- To examine the effects of Rac1 inhibition on vascular endothelial (VE)-cadherin and β-catenin expression in diabetic conditions.
Main Methods:
- Streptozotocin (STZ)-induced diabetic rat model.
- High glucose-induced rat retinal endothelial cells (RRECs).
- Rac1 activation measured by RT-qPCR, immunohistochemistry, and Western blot.
- VE-cadherin and β-catenin expression analyzed with and without Rac1 inhibition via siRNA.
Main Results:
- STZ-induced diabetes increased retinal vascular permeability and Rac1 activation.
- Rac1 activation was elevated in high glucose-induced RRECs.
- Rac1 inhibition prevented high glucose-induced decrease in VE-cadherin and normalized β-catenin expression.
- Rac1 inhibition ameliorated hyperpermeability in RRECs.
Conclusions:
- Diabetes induces changes in retinal Rac1 expression and activation.
- Rac1 plays a significant role in diabetes-induced blood-retinal barrier damage.
- Rac1 influences VE-cadherin and β-catenin expression, contributing to diabetic retinopathy pathogenesis.
Related Concept Videos
Diabetic Retinopathy
Type I Diabetes II: Pathophysiology
Diabetic Nephropathy
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type II Diabetes II: Pathophysiology
Diabetic Neuropathy

